galantamine

(redirected from Reminyl)
Also found in: Medical.
Related to Reminyl: Galantamine

ga·lan·tam·ine

 (gə-lăn′tə-mēn′)
n.
A drug, C17H21NO3, originally derived from the bulbs of snowdrops and other plants, that inhibits the action of acetylcholinesterase and is used in its hydrobromide form to treat dementia in people with Alzheimer's disease.

[Formed on the model of Russian galantamin : New Latin Galanthus, snowdrop genus name (coined by Carl Linnaeus in reference to the milk-white flowers of the snowdrop : Greek gala, milk; see melg- in Indo-European roots + Greek anthos, flower) + amine.]

galantamine

(ɡəˈlæntəˌmiːn)
n
(Pharmacology) a drug that, by blocking the action of the enzyme acetylcholinesterase in the cortex of the brain, has been used to slow down the cognitive decline that characterizes Alzheimer's disease
Translations

galantamine

n galantamina
References in periodicals archive ?
(1) Razadyne ([R]) (formerly Reminyl ([R])) and Nivalin ([R]) are licensed drugs of galantamine, currently available on the market.
The three available, Aricept, Reminyl and Exelon, work by slowing down the progression of the disease for some, but often don't work at all for others, sometimes making them feel even worse.
Galantamine (Razadyne, formerly known as Reminyl): This is the newest of the acetylcholinesterase inhibitors.
Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
There is another similar medicine called "Galantamine" (brand name: Reminyl) produced by Johnson and Johnson.
Another alkaloid, galantamine (Reminyl), isolated from Galanthus nivalis and Leucojum vernum is the additive to drugs used for the treatment of AD and was also licensed for use in early stages of AD in 2001.
For the irreversible types including Alzheimer's, vascular and Lewy-body dementia there are four common medications used: Donepezil (Aricept), Rivastigimine (Exelon), Memantine (Ebixa) and Galantamine (Reminyl).
The "cognitive enhancers" used by patients were Aricept, Namenda, Exelon, and Reminyl, drugs that have been approved for treating patients diagnosed with Alzheimer's disease and other forms of dementia.
One of the following acetylcholinesterase inhibitors: Donepezil (Aricept) 5-10 mg at night Rivastigmine (Exelon) 3-6 mg twice daily Galantamine (Reminyl) 16-24 mg daily and/or 2.
* Galantamine (Razadyne; previously marketed as Reminyl).
NICE's current guidance to medical practitioners on the prescription of Aricept, Reminyl, Excelon and Ebixa widens the use of these drugs to include more stages of Alzheimer's Disease.
Presently, many drugs are available in the market like Rivastigmine (Exelon), Donepezil (Aricept), Galantamine (Reminyl), and Tacrine (Cognex).